February, 2005:

Mylan and King announce merger is off

Americans in survey say drug industry cares more about profits than people

S&H names new EVP and director of brand planning

Government to pay nearly half of health costs within a decade

Abelson-Taylor partners with Omnicom’s Diversified Agency Services

Questions remain over COX-2 advertising

CommonHealth's Qi names new senior project director

FDA advisory panel votes to keep COX-2s on market

Fujisawa Selects GSW For Marketing Assignments

Merck researcher hints that company may again sell Vioxx

Dowden Health Media in talks to sell to Lebhar-Friedman

Prostate cancer vaccine shows promise in clinical trials

Advanstar reaches deal to provide content on 100 sites

AIDS foundation calls to pull Bristol-Myers Squibb ads

COX-2s pending approval may also carry heart risks

Michael Tansey tapped as chief of Wicks Medical Unit

GSK would cut sales force if Pfizer takes the lead

FDA weighs black box warning for two eczema creams

Redi-Mail Direct company adds dental association data

HMC Council forum focuses on ‘post-Vioxx’ marketing

Product, people and company News from this week's news brief

The Mattson Jack Group hires former Sanofi-Aventis director

PhRMA fires 14 PR firms in review

Ventiv wins Bayer work and promotes three

Merck researcher says all COX-2s may carry heart risk

FDA begins hearing on COX-2 drugs

FDA to establish new drug safety board

U.S. drug sales grow at slowest rate since 1995

Bush nominates Crawford to vacant FDA commissioner post

Advanced Health Media names new vice president of client services

Bush vows veto to any Medicare benefit changes

HMP adds two to its staff

Pfizer plans cut to $2 billion in costs, Wall Street Journal reports

Innovia creates three new positions

Stegall leaves Dudnyk and takes new role at Group DCA

Canada suspends sales of Shire’s Adderall XR

Medicare drug benefit to cost $720 billion over first ten years

Wachalter named senior partner at Flaum Partners Inc.

Schering-Plough hires Schmitt for global PR post

Pfizer reported to be eyeing cuts to sales, marketing

Bush budget boosts funding for FDA Office of Drug Safety

Corbett Accel names Broich as EVP, chief talent officer

COX-2s pending approval may also carry heart risks

GHG names two new senior vice presidents

Grey’s Lynn O’Connor Vos is HBA’s Woman of the Year

Nine drugs reach first-time blockbuster status in 2004

Vytorin takes lead in switches of cholesterol-lowering drugs

Crawford expected stay on as permanent FDA commissioner

Hill & Knowlton names Barton as new healthcare head

Sales force a ‘critical element’ of Pfizer’s five-year plan

Executive shake-up at Omnicom direct agency

Johnson & Johnson unit enters $310 million antibiotic deal

Ventiv division launches new direct mail-order pharmacy

Former HHS official calls for FDA to control Rx drug costs

Founding partner of Lally, McFarland & Pantello dies

Pfizer said it acted responsibly in sharing COX-2 data

Lilly's Taurel cites DTC for industry's deteriorating image

Antidepressant use in children dropped in 04

AstraZeneca chief executive sees changes ahead for DTC

S&H partners with Proscape Technologies

Pfizer admits 1999 trial linked Celebrex to heart risks

DeLor names new marketing executives